Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review.

Miguel RuizAlexandra CocoresAntonella TostiPeter J Goadsby Teshamae S Monteith

Published in: Cephalalgia : an international journal of headache (2023)

Most events were reported in women and non-serious. The potential mechanism of alopecia with drugs targeting calcitonin gene-related peptide or its receptor possibly includes disruptions in the microvascular circulation and other homeostatic mechanisms.

Keyphrases

polycystic ovary syndrome
case report
copy number
genome wide
cancer therapy
pregnancy outcomes
human health
cervical cancer screening
type diabetes
emergency department
breast cancer risk
binding protein
risk assessment
adipose tissue